PFE Latest Press Releases

-- December 2, 2025 --

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now Globe Newswire 8:30 AM

-- December 1, 2025 --

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance Business Wire 10:00 AM

-- November 24, 2025 --

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS) Globe Newswire 7:00 AM

-- November 21, 2025 --

U.S. FDA Approves PADCEV plus Keytruda for Certain Patients with Bladder Cancer Business Wire 1:24 PM

-- November 20, 2025 --

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For Globe Newswire 8:30 AM

-- November 13, 2025 --

Pfizer Completes Acquisition of Metsera Business Wire 11:26 AM

-- November 12, 2025 --

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire 10:00 AM

-- November 11, 2025 --

Johnson Fistel Investigates Fairness of Proposed Sale of Metsera Globe Newswire 1:57 PM

-- November 5, 2025 --

Pfizer Responds to Delaware Chancery Court Ruling Business Wire 5:08 PM

-- November 4, 2025 --

Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance Business Wire 6:45 AM

-- November 3, 2025 --

Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk Business Wire 7:57 AM

-- October 31, 2025 --

Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement Business Wire 4:37 PM

Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition Business Wire 3:50 PM

-- October 30, 2025 --

Pfizer Addresses Proposal for Metsera Business Wire 6:57 AM

-- October 23, 2025 --

Metsera Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR Business Wire 12:15 PM

-- October 20, 2025 --

Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy Globe Newswire 4:15 AM

-- October 19, 2025 --

XTANDI Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer Business Wire 4:15 AM

Pfizer's BRAFTOVI + MEKTOVI Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer Business Wire 2:30 AM

-- October 18, 2025 --

PADCEV Plus KEYTRUDA , Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer PRNewswire 10:30 AM

-- October 17, 2025 --

ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain Business Wire 7:00 AM

-- October 15, 2025 --

ViiV Healthcare's CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir Business Wire 7:00 AM

-- October 14, 2025 --

TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial Business Wire 6:45 AM

-- October 13, 2025 --

Arvinas to Present Data from the Vepdegestrant Clinical Development Program at the 2025 European Society for Medical Oncology (ESMO) Congress Globe Newswire 7:00 AM

Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 Business Wire 6:45 AM

-- October 9, 2025 --

Pfizer Declares Fourth-Quarter 2025 Dividend Business Wire 4:30 PM

ViiV Healthcare showcases breadth of clinical and real-world evidence at EACS and IDWeek 2025 Business Wire 9:00 AM

-- October 1, 2025 --

Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025 PRNewswire 2:00 AM

-- September 30, 2025 --

Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Business Wire 12:45 PM

-- September 25, 2025 --

Hearing Against Pfizer Set For 29 September In Contraceptive 'Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio Business Wire 3:37 PM

Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025 Business Wire 6:45 AM

-- September 23, 2025 --

METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR Business Wire 6:00 PM

Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts Business Wire 10:00 AM

-- September 22, 2025 --

Johnson Fistel Investigates Fairness of Proposed Sale of Metsera Globe Newswire 12:20 PM

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio Business Wire 6:45 AM

-- September 17, 2025 --

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation Globe Newswire 4:30 PM

-- September 16, 2025 --

Top 20 Companies Recognized in Labrador Transparency's 2025 U.S. Transparency Awards Business Wire 8:29 AM

-- September 8, 2025 --

Stopping Cancer Before It Spreads: The EMT Revolution in Oncology Yolowire 3:43 PM

The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access Yolowire 3:29 PM

Stopping Cancer Before It Spreads: The EMT Revolution in Oncology Yolowire 7:15 AM

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula Business Wire 6:45 AM

-- September 3, 2025 --

The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access Yolowire 7:44 AM

-- September 2, 2025 --

Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer Globe Newswire 7:00 AM

-- September 1, 2025 --

??? ??? ???? ???? ? ?? '??' ??? ???? ? CDC ?? ???? ???: '?? ??? ???'? ?? ? Shomik Sen Bhattacharjee 3:47 AM

Le leadership de Robert Kennedy Jr. ne peut apporter que plus de "dommages", dclare un haut responsable de l'ancien CDC : "Le dmantlement de la vaccination" est en cours Shomik Sen Bhattacharjee 3:47 AM

????????Jr.???????????CDC????????????????????????????????????????????? Shomik Sen Bhattacharjee 3:47 AM

??? ???? ?????? ????? ?????? ??????? ??????: "????? ????? ?????? ?????? ?????? ??? ????? ?????? ?? ?????: '????? ???????' ?? ???????". Shomik Sen Bhattacharjee 3:47 AM

??????????????????"??",?????????????:"???????????" Shomik Sen Bhattacharjee 3:47 AM

Il leadership di Robert Kennedy Jr. pu solo portare pi "danno", afferma il ex funzionario di alto livello dei CDC: "Disfazione della vaccinazione" in corso Shomik Sen Bhattacharjee 3:47 AM

Robert Kennedy Jr.'s Fhrung wird laut einem fhrenden ehemaligen CDC-Beamten nur noch mehr "Schaden" bringen: "Rckgngigmachung der Impfung" in Arbeit Shomik Sen Bhattacharjee 3:47 AM

El liderazgo de Robert Kennedy Jr. solo puede traer ms "dao", dice alto exfuncionario de los CDC: "Desmantelamiento de la vacunacin" en proceso Shomik Sen Bhattacharjee 3:47 AM

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works Shomik Sen Bhattacharjee 3:46 AM

-- August 30, 2025 --

?? ???, CDC ??? ?? ?? ??? ??? ?? RFK ??? ?? ?? Mohd Haider 10:55 PM

??????????CDC??????????????????????RFK Jr.?????? Mohd Haider 10:55 PM

Bernie Sanders exige la dmission du secrtaire la sant RFK Jr. alors que la crise du leadership au CDC s'aggrave Mohd Haider 10:55 PM

???? ?????? ????? ???????? ???? ????? RFK Jr. ?? ????? ???? ????? ???? ??????? ??? ??????? ???????? ???? Mohd Haider 10:55 PM

Bernie Sanders fordert den Rcktritt von Gesundheitsminister RFK Jr., da sich die Fhrungskrise der CDC vertieft Mohd Haider 10:55 PM

Bernie Sanders chiede le dimissioni del Segretario alla Salute RFK Jr. mentre si approfondisce la crisi di leadership dei CDC Mohd Haider 10:55 PM

????????????????,CDC?????? Mohd Haider 10:55 PM

Bernie Sanders exige la renuncia del Secretario de Salud RFK Jr. a medida que la crisis de liderazgo de los CDC se profundiza Mohd Haider 10:55 PM

Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens Mohd Haider 10:55 PM

-- August 27, 2025 --

Pfizer and BioNTech's COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 Globe Newswire 12:50 PM

Pfizer and BioNTech's COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 Business Wire 12:50 PM

-- August 12, 2025 --

PADCEV Plus KEYTRUDA Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery Business Wire 5:30 AM

-- August 8, 2025 --

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer Globe Newswire 4:05 PM

-- August 5, 2025 --

Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance Business Wire 6:45 AM

-- July 25, 2025 --

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union Globe Newswire 2:30 AM

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union Business Wire 2:30 AM

-- July 24, 2025 --

Pfizer Faces US Lawsuits After Study Links Depo-Provera Birth Control to Higher Risk of Brain Tumors Benzinga Newsdesk 7:07 AM

Pfizer's 'Depo-Provera' Increases Risk of Brain Tumours 3.5 Times Compared to Combined Birth Control Pill According to New Study as Litigation Overseen by Levin Papantonio Rises to Over 550 Lawsuits Globe Newswire 7:00 AM

Pfizer Completes Licensing Agreement with 3SBio Business Wire 6:45 AM

-- July 17, 2025 --

Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis (apixaban) Option Business Wire 6:59 AM

-- July 14, 2025 --

ViiV Healthcare data show 89% of treatment-nave people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression Business Wire 9:35 AM

ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment Business Wire 9:28 AM

-- July 10, 2025 --

XTANDI Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence Business Wire 6:45 AM

-- July 8, 2025 --

ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025 Business Wire 9:34 AM